Bernard R. Neustadt

Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Bernard R. Neustadt, Jinsong Hao, Neil Lindo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 137 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(<i>S</i>)-methyl-4-[1(<i>S</i>)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine <i>N</i>1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist

Jayaram R. Tagat, Ruo W. Steensma, Stuart W. McCombie et al. · Journal of Medicinal Chemistry · 2001 · 113 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

Robert A. Hodgson, Paul J. Bédard, Geoffrey B. Varty et al. · Experimental Neurology · 2010 · 96 citations

Medicine, Neuroscience, Pharmacology +8

Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity

Ho-Sam Ahn, Ana Bercovici, George Boykow et al. · Journal of Medicinal Chemistry · 1997 · 80 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Facile preparation of N-(sulfonyl)carbamates

Bernard R. Neustadt · Tetrahedron Letters · 1994 · 65 citations

Natural Sciences, Chemistry, Medicinal Chemistry +3